First, I wonder if SA is going to get out his "Magic Check Book". Perhaps he will start writing magic checks if CRY's stock price should fall below $5.50, the level at which CRY has previously bought back shares. CRY might be in lock-up right now though, I don't know.
Second, during the CC on the 30th, I would like to know why CRY continues to operate the "cardiac" and "vascular" tissue cost centers. WHY? It appears that these two cost centers are "ZERO", or at best "NEAR ZERO", "net operating income" cost centers. These cost centers have a potential liability tail too, flash back to Brian Lykins in 2001. These cost centers take up a lot of employee time. Also, it appears that the pending "FDA" matter results largely from the processing of "cardiac" and "vascular" tissue, although BioGlue was mentioned as well. SA never answers this question. I think he is afraid to tell shareholders the truth about the lack of profitability at these two cost centers.